Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calcium lead limit sought by NRDC "not scientifically defensible" or "feasible," FDA told.

This article was originally published in The Tan Sheet

Executive Summary

CALCIUM LEAD LIMIT REQUESTED BY NRDC "NOT SCIENTIFICALLY DEFENSIBLE" or "commercially feasible," the Council for Responsible Nutrition and Nonprescription Drug Manufacturers Association argue in a June 10 joint citizen petition to FDA. The filing responds to the January petition by the Natural Resources Defense Council seeking an FDA-established upper limit of .5 mcg of lead per maximum recommended daily dosage for calcium supplements and antacid products ("The Tan Sheet" Feb. 3, p. 9). The .5 mcg/day level is based on California's Proposition 65 limit for lead.

You may also be interested in...



Lower Lead Limits For Calcium-Containing Products Shelved By FDA

FDA is not adopting new, lower lead limits for calcium-containing supplements and antacids at this time but "is actively investigating the feasibility of establishing lower limits," the agency tells the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a Sept. 28 letter.

Lower Lead Limits For Calcium-Containing Products Shelved By FDA

FDA is not adopting new, lower lead limits for calcium-containing supplements and antacids at this time but "is actively investigating the feasibility of establishing lower limits," the agency tells the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a Sept. 28 letter.

Lower Lead Limits For Calcium-Containing Products Shelved By FDA

FDA is not adopting new, lower lead limits for calcium-containing supplements and antacids at this time but "is actively investigating the feasibility of establishing lower limits," the agency tells the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a Sept. 28 letter.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel